Skip to the main content.
About Us

BMES serves as the lead society and professional home for biomedical engineers and bioengineers. BMES membership has grown to over 6,000 members, with more than 160 BMES Student Chapters, three Special Interest Groups (SIGs), and four professional journals.

BMES Hub

Welcome to the BMES Hub, a cutting-edge collaborative platform created to connect members, foster innovation, and facilitate conversations within the biomedical engineering community.

BMES Hub

Sponsor & Exhibitor Prospectus

Discover all of the ways that you can boost your presence and ROI at the 2024 BMES Annual Meeting. Browse a range of on-site and digital promotional opportunities designed to suit any goal or budget that will provide maximum impact.

1 min read

NANOGELS DEVELOPED AT U OF TEXAS COULD DELIVER NUMEROUS THERAPEUTIC TREATMENTS TO TREAT CANCER

Researchers at The University of Texas at Austin have developed new guidelines for fabricating nanoscale gel materials, or nanogels, that can deliver numerous therapeutic treatments to treat cancer in a precise manner, the university announced.

In addition to enabling the delivery of drugs in response to tumors, the nanogels can target malignant cells, degrade into nontoxic components and execute multiple clinical functions, the article states.

The most important characteristic of the engineering researchers' nanogels is their ability to be chemically modified or “decorated” with many bioactive molecules, the article continues. These modifications give the decorated nanogels more diverse physical and chemical properties than any other existing technique, despite their identical origin. Such systems, which have the potential of being tailored to specific diseases or even individual patients, could be a useful tool for oncologists in the future.

A study published in Science Advances details the work. 

The research team is led by drug delivery pioneer Nicholas Peppas, a professor in the departments of biomedical engineering and chemical engineering and a BMES fellow. 

The UT College of Pharmacy and the Dell Medical School, conducted the study over four years at UT's Institute for Biomaterials, Drug Delivery & Regenerative Medicine, which Peppas directs. 

“One way to think of our nanogel is like a blank canvas,” said John Clegg, who was a Ph.D. candidate in the Cockrell School when he worked on the study and is currently a postdoctoral fellow at Harvard University. Clegg is also a BMES member. “Untouched, a blank canvas is nothing more than some wood and fabric,” he said in the article. “Likewise, the nanogel is a simple structure (made of polymer-joining agents and water).  When it is modified, or decorated, with different bioactive groups, it retains the activity of each added group. So, the system can be quite simple or quite sophisticated.”

Read more HERE.

Gordana Vunjak-Novakovic Opens BMES Annual Meeting

Gordana Vunjak-Novakovic Opens BMES Annual Meeting

This is the fifth in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024 Annual...

Read More
NIH Prize Competitions: Crowdsourcing Biomedical Innovation

NIH Prize Competitions: Crowdsourcing Biomedical Innovation

This is the sixth and final article in a series highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024...

Read More
Grand Challenges Seek to Reset Bioengineering Agenda

Grand Challenges Seek to Reset Bioengineering Agenda

This is three in a series of articles highlighting some of the technologies, processes and keynote plenary sessions presented at the 2024 Annual...

Read More
NORTHWESTERN RESEARCHERS FIND DISORDERLY DNA HELPS CANCER CELLS EVADE TREATMENT, DISCOVERY COULD HEL

1 min read

NORTHWESTERN RESEARCHERS FIND DISORDERLY DNA HELPS CANCER CELLS EVADE TREATMENT, DISCOVERY COULD HEL

A new Northwestern University study has discovered that the packing of the three-dimensional genome structure, called chromatin, controls how cells...

Read More
NORTHEASTERN ENGINEERS INVESTIGATE USING NANOPARTICLES TO TREAT COVID-19 AND OTHER VIRUSES

1 min read

NORTHEASTERN ENGINEERS INVESTIGATE USING NANOPARTICLES TO TREAT COVID-19 AND OTHER VIRUSES

Northeastern chemical engineer Thomas Webster, who specializes in developing nano-scale medicine and technology to treat diseases, is part of a...

Read More
HANDHELD 3D PRINTERS DEVELOPED AT UCONN TO TREAT MUSCULOSKELETAL INJURIES

1 min read

HANDHELD 3D PRINTERS DEVELOPED AT UCONN TO TREAT MUSCULOSKELETAL INJURIES

Biomedical engineers at the UConn School of Dental Medicine have developed a handheld 3D bioprinter that could change the way musculoskeletal...

Read More